Specifically, tumor-derived PGE2 directly induces the production of cancer-promoting inflammatory mediators, such as IL-6, CXCL1, and G-CSF, by myeloid cells, while preventing the activation of anti-tumor type I immune responses [229]. This evidence concerns the gene IL6 and cancer.